Floatz logo

VITAMIN D

Restless Leg Disorder

University of Sao Paulo General HospitalmixturePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Restless Leg Disorder cohort.

Asset / SponsorPhaseRating
Ropinirole
GlaxoSmithKline
Phase 4A
FERRIC CATION
University of Zurich
Phase 4BBB
IRON(II) SULPHATE (1:1), HEPTAHYDRATE
Mayo Clinic
Phase 4BB
Ctc-501
Massachusetts General Hospital
Phase 4BB
Ferumoxytol
Auerbach Hematology Oncology Associates P C
Phase 2B

View all 9 →

Same molecule, other indications

VITAMIN D is also rated in:

vitamin D deficiencyDormant
A
Indicative ·
83 / 100
View asset →
osteoporosisDormant
BBB
Indicative ·
76 / 100
View asset →
polycystic ovary syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →